← Back to Search

Behavioural Intervention

ATTACH™ Parenting Program for Strengthening Parent-Child Relationships (ATTACH™ Trial)

N/A
Recruiting
Led By Nicole Letourneau, PhD RN
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline asq-3 scores immediately after completion of intervention and at 3 months.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an intervention program to help parents of young kids at risk of early adversity (e.g., family violence, parental depression, and low income) to strengthen parent-child relationships and improve child mental health.

Who is the study for?
This trial is for parents with children from birth to 32 months old, who are willing to participate in a 10-week online parenting program. The program includes one-hour weekly training sessions and encourages bringing a co-parent for two of the sessions if possible.
What is being tested?
The ATTACH™ Online Platform Parenting Program is being tested. It's designed to improve parent-child relationships and child development by enhancing parents' understanding of their own and their child's thoughts and feelings, especially after early adversity like family violence or parental depression.
What are the potential side effects?
Since this intervention involves an educational parenting program rather than medical treatment, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress while engaging with the material or reflecting on personal experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline pcits scores immediately after completion of intervention and at 3 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline pcits scores immediately after completion of intervention and at 3 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Children's Mental Health and Development
Secondary study objectives
Parent-Child Relationship Quality
Parental Reflective Function (RF)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ATTACH™ Online Platform Parenting ProgramExperimental Treatment1 Intervention
A quasi-experimental design was selected to more closely approximate service delivery models in agencies that do not typically employ control groups. Given promising findings (from seven ATTACH™ pilot studies), a randomized controlled trial design, even employing wait-list controls, was deemed unacceptable and even unethical by patients, healthcare professionals, and health system administrators in engagement activities surrounding the preparation of this proposal.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
811 Previous Clinical Trials
889,416 Total Patients Enrolled
Nicole Letourneau, PhD RNPrincipal InvestigatorUniversity of Calgary

Media Library

ATTACH™ Online platform (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05994027 — N/A
Parent-Child Relationship Research Study Groups: ATTACH™ Online Platform Parenting Program
Parent-Child Relationship Clinical Trial 2023: ATTACH™ Online platform Highlights & Side Effects. Trial Name: NCT05994027 — N/A
ATTACH™ Online platform (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05994027 — N/A
~51 spots leftby Dec 2025